Skip to Content

Comparing Downstaging in RCC-patients with Tumor or Without Tumor Thrombus Receiving Neoadjuvant ICI Regimen

This study compares the effects of neoadjuvant immune-oncology (IO) based regimens on patients with renal cell carcinoma (RCC) with and without tumor thrombus. Listen to Wadih Issa from UT Southwestern present the results of the study in this MEDtalk from ASCO GU 2024.

Wadih Issa

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top